AG
ARNA

Advisor Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Advisor Group’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$160K Sell
3,496
-1,346
-28% -$63.6K ﹤0.01% 2572
2019
Q3 		$222K Sell
4,842
-14,302
-75% -$804K ﹤0.01% 2243
2019
Q2 		$1.12M Buy
19,144
+14,969
+359% +$774K 0.01% 1063
2019
Q1 		$186K Sell
4,175
-820
-16% -$37.6K ﹤0.01% 2343
2018
Q4 		$194K Buy
4,995
+295
+6% +$11.6K ﹤0.01% 2116
2018
Q3 		$217K Sell
4,700
-312
-6% -$12.6K ﹤0.01% 2099
2018
Q2 		$219K Buy
5,012
+677
+16% +$29.1K ﹤0.01% 1910
2018
Q1 		$170K Buy
4,335
+1,979
+84% +$77K ﹤0.01% 2101
2017
Q4 		$79K Sell
2,356
-55
-2% -$1.57K ﹤0.01% 2755
2017
Q3 		$61K Sell
2,411
-540
-18% -$12.4K ﹤0.01% 2792
2017
Q2 		$50K Sell
2,951
-381
-11% -$5.22K ﹤0.01% 2862
2017
Q1 		$49K Sell
3,332
-14,382
-81% -$213K ﹤0.01% 2728
2016
Q4 		$252K Sell
17,714
-618
-3% -$9.57K 0.01% 1398
2016
Q3 		$321K Sell
18,332
-1,685
-8% -$27.9K 0.01% 1230
2016
Q2 		$341K Buy
+20,017
New +$358K 0.01% 1127

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Advisor Group's ARNA Position: Q4 2019 in Review

Advisor Group reduced its Arena Pharmaceuticals Inc (ARNA) stake by 28% in Q4 2019, selling an estimated $63.6K and leaving 3,496 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Advisor Group first reported a position in ARNA in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.12M in Q2 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • Advisor Group held 3,496 shares of Arena Pharmaceuticals Inc worth $160K as of Q4 2019.
  • Advisor Group sold 1,346 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $63.6K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2572 holding.
  • Advisor Group first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Arena Pharmaceuticals Inc position peaked at $1.12M in Q2 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.